TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Curcumin, Arsenic trioxide
Phytochemical Name Curcumin (PubChem CID: 969516 )
Anticancer drug Name Arsenic trioxide (PubChem CID: 14888 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 400
Pair Name Curcumin, Arsenic trioxide
Disease Info [ICD-11: 2A60.Z] Acute myeloid leukemia Investigative
Gene Regulation Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Down-regulation Expression JAK2 hsa3717
Up-regulation Expression PSMD9 hsa5715
Down-regulation Expression STAT3 hsa6774
Up-regulation Expression TP53 hsa7157
In Vitro Model KG-1a Adult acute myeloid leukemia Homo sapiens (Human) CVCL_1824
In Vivo Model All mice were inoculated with KG1-a cells via the tail vein after pretreatment of 48 h, approximately 1.0×10⁷ cells per mouse.
Result Our results suggested that curcumin and As2O3 combination therapy exerts more significant anti-leukemia effects in the treatment of AML than curcumin or As2O3 monotherapy by up-regulating p53 pathway and down-regulating the JAK2/STAT3 pathway.
03. Reference
No. Title Href
1 Curcumin combined with arsenic trioxide in the treatment of acute myeloid leukemia: network pharmacology analysis and experimental validation. J Cancer Res Clin Oncol. 2023 Jan;149(1):219-230. doi: 10.1007/s00432-022-04463-7. Click
It has been 26614 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP